Regenerative Medical Solutions
Dr. Alan Lewis currently serves as an advisor to biotech companies. He has served as President, CEO and Director of Ambit Biosciences, a privately-held biotech company. He has also served as President and CEO of the Juvenile Diabetes Research Foundation (JDRF) and Novocell (ViaCyte). Prior to joining Novocell, was President of Celgene’s Signal Research, a wholly-owned subsidiary of the Celgene Corporation. He was President, CEO, and Director of Signal Pharmaceuticals, where he guided the company to its successful acquisition by Celgene. He previously was Vice President of Research at Wyeth. Dr. Lewis completed a postdoctoral fellowship at Yale University after obtaining a Ph.D. in pharmacology from the University of Wales in Cardiff. Dr. Lewis serves as a director on the boards of Biomarin, Ctyochroma, and Biotica.
This person is not in the org chart
This person is not in any offices
Regenerative Medical Solutions
Regenerative Medical Solutions, Inc., is a start-up biotechnology company originating from Dr. Jon Odorico’s laboratory’s academic research at the University of Wisconsin. They were founded in 2012 with a vision to harness the regenerative property of human-induced pluripotent stem cells (iPSCs) to produce pancreatic β (beta) islet cells to cure diabetes.